Medicines authorised in Romania

Tecentriq

Tecentriq is a medicine containing Atezolizumab, listed in the Romanian national register of medicines for human use with 2 presentations.

General information from the official register, not medical advice. Anpheros does not diagnose and does not recommend medicines. Read the package leaflet and ask your doctor or pharmacist before taking any medicine.

At a glance

Active substance
ATEZOLIZUMAB
ATC code
L01FF05 Antineoplastic and immunomodulating agents
Therapeutic action
ANTICORPI MONOCLONALI SI CONJUGATI
ANTICORPI MONOCLONALI
Prescription
Prescription required (register code PR)
Marketing authorisation holder
ROCHE REGISTRATION GMBH - GERMANIA
Manufacturer
ROCHE PHARMA AG - GERMANIA
Pharmaceutical form
CONC. PT. SOL. PERF.
SOL. INJ.

Presentations and codes

CIM is the code of each pack in the Romanian register; the Anpheros app saves it when it recognises the box.

CIM codeFormStrengthPackPrescriptionAuthorisationShelf life
W64295001CONC. PT. SOL. PERF.1200mg/20mlCutie cu 1 flac. din sticla x 20 ml conc. pt. sol. perf.PR1220/2017/013 ani
W69966001SOL. INJ.1875mg/15mlCutie cu 1 flac. din sticla x 15 ml sol.inj.PR1220/2017/032 ani

What it is used for

The official indications for Atezolizumab, quoted from the European Medicines Agency and the US FDA, are on Atezolizumab in Anpheros Search.

The package leaflet and the summary of product characteristics are published by ANMDMR: search for “Tecentriq” in the national register.

Scan the box in Anpheros

In the Anpheros Daily app, photograph the medicine box: the app reads the name and strength, matches them against this register and adds the medicine to your list, with its code. From your list you can come back to this page.

Get the app

Source: ANMDMR — National Agency for Medicines and Medical Devices of Romania, Nomenclatorul medicamentelor de uz uman (register updated 29 October 2026). Shown as published, in Romanian where the register is in Romanian.